I am a
Home I AM A Search Login

Papers of the Week


Papers: 22 Oct 2022 - 28 Oct 2022


Pharmacology/Drug Development

PAIN TYPE:
Itch


2022 Oct 27


Expert Rev Clin Immunol

Tailored biological treatment for patients with moderate to severe psoriasis.

Authors

Maurelli M, Gisondi P, Girolomoni G
Expert Rev Clin Immunol. 2022 Oct 27.
PMID: 36300752.

Abstract

Psoriasis is a common, chronic immune-mediated skin disease frequently associated to inflammatory and metabolic comorbidities. About 20-30% of patients are affected by moderate-to-severe psoriasis and require a systemic treatment, which include traditional and biological drugs. The objective of this manuscript is to provide criteria for a personalized biological treatment.